Provide scientific leadership across all clinical programs from early development through late‑stage global registrational trials.
Oversee authorship, development, and strategic review of protocols, IBs, SAPs, CSRs, DSURs, ICFs, eCRFs, and clinical modules of major submissions.
Lead global regulatory interactions (FDA, EMA, MHRA, PMDA), including briefing docs, written responses, and meeting preparations.
Direct quantitative strategy across programs, integrating clinical data, real‑world evidence, model‑informed drug development, and exploratory biomarker analyses.
Ensure robust data quality, oversee scientific data reviews, and resolve complex data issues.
Lead scientific strategy for regulatory submissions (IND, CTA, BLA, MAA, sBLA/sNDA).
Drive scientific publication strategy and represent the company in scientific forums.
Provide leadership to Clinical Scientists, Statisticians, and cross‑functional partners.
Requirements
Advanced degree required (PhD, PharmD, MD, or equivalent).
8+ years industry experience in clinical development, clinical science, or quantitative sciences.
Significant global submission experience in oncology or urology disease area with direct leadership of key modules. Experience in bladder cancer disease area is preferred.
Demonstrated leadership in designing and executing complex Phase I–III clinical trials.
Experience leading scientific interactions with global health authorities.
Deep understanding of biostatistics, data management, and real‑world data integration.
Experience building and managing high‑performing scientific and data teams.